SCHEMBL7474497

SCHEMBL7474497

CCCCCCOc1nc(CC)c(-c2c(OC)cccc2OC)nc1CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.40
TLR8 Q9NR97 1/20 0.38
MEN1 O00255 1/20 0.37
NR1I2 O75469 1/20 0.37
LMNA P02545 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADRA2A P08913 1/20 0.37
MAPT P10636 1/20 0.37
OPRK1 P41145 1/20 0.37
HTR2B P41595 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DHFR P00374 1/20 0.36
ALOX5 P09917 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475280 0.99 MCHR1 (0.39) MCHR1TLR8MEN1NR1I2LMNA
SCHEMBL7478697 0.79 CRHR1 (0.49)
SCHEMBL6202588 0.77 CRHR1 (0.38) SMN1; SMN2
SCHEMBL6201091 0.77 CRHR1 (0.43)
SCHEMBL7477213 0.76 CRHR1 (0.39)
SCHEMBL7482386 0.76 CRHR1 (0.42) MEN1MAPTKMT2AALOX5PTGS2
SCHEMBL6203954 0.76 CRHR1 (0.44)
SCHEMBL5406538 0.75 CRHR1 (0.40) LMNAMAPTALDH1A1
SCHEMBL5417812 0.75 CRHR1 (0.48) MCHR1
SCHEMBL7470192 0.75 CRHR1 (0.59) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP disclosed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO disclosed